Australian investors see hope in ENA Respiratory, a nasal spray specialist aiming to complement global COVID-19 vaccine programs with an immune system-boosting product
Australia’s Brandon Capital, a life sciences VC firm, and Minderoo Foundation, a non-profit that has pivoted much of its activity toward stemming the pandemic, are used to dismissing investment opportunities...
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
Best & Less Group (BLG), an Australian baby, kids and womenswear retailer, has raised A$60 million ($44 million) through a domestic IPO, facilitating a partial exit for majority owner Allegro Funds Group.
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
B Capital Group has hired Sheila Patel, formerly the Singapore-based chairman of Goldman Sachs Asset Management, as a vice president amid a concerted Asian expansion drive.